We demonstrated that PD-1+ and LAG-3+ TILs were present in approximately 30% and 18% of TNBCs, respectively, and that their presence in the tumor microenvironment tended to be associated with good prognosis in TNBC. The gene discussed is LAG3; the disease is neoplasm.